Effects of Electrical Muscle Stimulation on Myofascial Pain Syndrome
2 other identifiers
interventional
65
1 country
1
Brief Summary
The goal of this clinical trial is to determine if Electrical Muscle Stimulation (EMS) combined with Active Stretching (AS) (EMS+AS) and EMS+AS combined with Trigger Point Pressure Release (TPR) (EMS+AS+TPR) are effective treatments for Myofascial Pain Syndrome (MPS) in working adults. The study will also assess the safety of the EMS+AS intervention. The main questions it aims to answer are: Do EMS+AS and EMS+AS+TPR lead to greater pain reduction, increased pressure pain threshold, and improved surface electromyography (sEMG) activity when compared to standard treatments? Furthermore, what is the participant feedback regarding EMS+AS and other treatments? Researchers will compare EMS+AS to passive stretching (PS) and TPR to see if EMS+AS and EMS+AS+TPR are effective in treating myofascial trigger points in the trapezius muscle. Participants will receive seven interventions across a single visit, including PS, EMS+AS, TPR, TPR combined with AS (TPR+AS), EMS+AS+TPR, Sham stimulation, and Transcutaneous Electrical Nerve Stimulation (TENS). Each treatment will consist of three 10-second sets with a 10-second rest between sets, and a 2-minute break provided between different treatments. Participants will have measurements taken on changes in pain intensity, pressure pain threshold, and sEMG activity during trapezius action pre- and post-treatment. Additionally, participants will report personal information, previous MPS treatments, and baseline health status, and provide feedback on satisfaction, treatment preferences, exercise knowledge for MPS prevention, and qualitative comments. For supplementary data, we selected only the EMS+AS and TPR interventions with the same protocol to evaluate changes in range of motion and changes in trigger point size and trapezius thickness (both at rest and during stretching) via ultrasound imaging.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 20, 2025
CompletedFirst Submitted
Initial submission to the registry
November 27, 2025
CompletedFirst Posted
Study publicly available on registry
January 2, 2026
CompletedJanuary 2, 2026
December 1, 2025
1.3 years
November 27, 2025
December 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Changes in Pain intensity
Changes in pain intensity before and after treatment were measured using a numeric rating scale (0-10), where 0 represents no pain and 10 represents the worst possible pain. A reduced score indicates a better outcome.
Baseline and Day 1 (immediately post-intervention)
Changes in pressure pain threshold
Changes in pressure pain threshold between before and after treatment were measured using a digital algometer (Wagner, Greenwich, USA). Pressure pain threshold was measured in kilogram force (kgf) or kilograms per square centimeter (kg/cm²). An increased score indicates a better outcome.
Baseline and Day 1 (immediately post-intervention)
Changes in median frequency of EMG activity
Changes in the median frequency of surface electromyography (EMG) before and after treatment were recorded in hertz (Hz) using a 16-channel sEMG (Delsys Trigno Maize Sensor system). Changes in median frequency reflect physiological changes in muscle function. An increase in median frequency during trapezius muscle activity indicates physiological improvement.
Baseline and Day 1 (immediately post-intervention)
% maximum volunatary contraction (MVC) improvement
%MVC improvement of EMG activity before and after treatment was recorded in percent (%) after calculating the root mean square normalized to pre-treatment values using a 16-channel sEMG (Delsys Trigno Maize Sensor system). An increase in %MVC during trapezius muscle activity indicates muscle function improvement.
Baseline and Day 1 (immediately post-intervention)
Secondary Outcomes (4)
Changes in range of motion (ROM) of neck deviation
Baseline and Day 1 (immediately post-intervention)
Changes in myofascial trigger point (MTP) size
Baseline and Day 1 (immediately post-intervention)
Changes in echointensiy at the myofascial trigger point (MTP)
Baseline and Day 1 (immediately post-intervention)
Changes in trapezius muscle thickness
Baseline and Day 1 (immediately post-intervention)
Other Outcomes (1)
Particpants' feedback
Day 1 (Post-treatment assessment)
Study Arms (7)
Therapist-assisted Passive stretching (PS)
ACTIVE COMPARATORPassive Stretching with Therapist Assistance: The protocol consisted of three sets of stretching. Each set was performed for 10 seconds and followed by a 10-second break, totaling one minute for the single session.
The two-combination of EMS+AS
EXPERIMENTALElectrical Muscle Stimulation (EMS) combined with Active Stretching (AS) was applied to the upper or middle trapezius muscle to facilitate muscle elongation. The protocol consisted of three sets of performing. Each set was performed for 10 seconds and followed by a 10-second break, totaling one minute for the single session.
Trigger point pressure release (TPR)
ACTIVE COMPARATORTrigger Point Pressure Release (TPR): TPR was directly applied to the MTP of upper or middle trapezius muscle.The protocol consisted of three sets of performing. Each set was performed for 10 seconds and followed by a 10-second break, totaling one minute for the single session.
Trigger point pressure release combined with active stretching (TPR+AS)
OTHERTrigger Point Pressure Release (TPR) combined with Active Stretching (AS) was performed either by using neck deviation for the upper trapezius muscle or by using scapula protraction for the middle trapezius muscle during TPR. The protocol consisted of three sets of performing. Each set was performed for 10 seconds and followed by a 10-second break, totaling one minute for the single session.
The triple combination therapy of EMS+AS+TPR
EXPERIMENTALThis triple combination therapy was applied to enhance MTP release in the upper or middle trapezius muscles. The protocol consisted of three sets of performing. Each set was performed for 10 seconds and followed by a 10-second break, totaling one minute for the single session.
Transcutaneous electrical nerve stimulation (TENS)
ACTIVE COMPARATORTranscutaneous Electrical Nerve Stimulation (TENS) was applied on the upper or middle trapezius muscles without stretching. The protocol consisted of three sets of operating. Each set was performed for 10 seconds and followed by a 10-second break, totaling one minute for the single session.
Sham stimulation combined with active stretching (SS+AS)
SHAM COMPARATORSS+AS consisted only of active stretching of the upper or middle trapezius muscle, with no electrical current applied from EMS device. Self-stretching was performed for three sets, with each 10-second stretch followed by a 10-second break, resulting in a total session time of one minute.
Interventions
The therapist stretched the upper trapezius muscle via shoulder depression and neck deviation. The middle trapezius muscle was stretched using scapular protraction while simultaneously stabilizing the mid-spine and gently pulling the arm inward.
Electrical Muscle Stimulation combined with Active Stretching: The EMS component utilized parameters of 20 Hz frequency and 100 µs pulse width, with the amplitude adjusted individually for intensity. The EMS electrodes were placed across the muscle fibers with a 1 cm inter-electrode distance. This placement was specifically designed to restrict the electrical field, thereby inducing a local muscle contraction that opposes the direction of the active stretch being performed concurrently.
Trigger point Pressure Release (TPR): The therapist utilized a PAIN TEST™ FPX series pressure gauge (Wagner Instruments). A round rubber 1 cm2 force gauge probe was applied directly on the MTP by gradually increasing the pressure until the participant reached their maximum pressure tolerance level.
Trigger point Pressure Release combined with Active Stretching (TPR+AS) was performed by applying active stretching of the trapezius muscle concurrently with TPR, using the same protocol as the standalone TPR intervention.
Electrical Muscle Stimulation combined with Active Stretching during Trigger point Pressure Release (EMS+AS+TPR): This triple combination therapy utilized the EMS+AS component protocol concurrently with the TPR intervention, applying the identical protocols established for the standalone EMS+AS and TPR procedures.
Transcutaneous Electrical Nerve Stimulation (TENS) was applied using the conventional protocol (60 Hz,100 µs,5 mA) with two electrodes placed directly over the MTP region, without stretching.
Sham stimulation combined with active stretching (SS+AS): Participants performed AS using the same EMS device and electrode placement as in the EMS+AS protocol. However, no electrical current was applied. The procedure began with a conversation about the treatment from the researcher while the current amplitude was reduced from 1 mA to 0 mA during the trapezius muscle stretching, accompanied by a beeping sound to simulate stimulation. Participants were subsequently informed that this was the intended treatment.
Eligibility Criteria
You may qualify if:
- Participants over 18 years old with either active or latent myofascial trigger points in the trapezius muscle were diagnosed with MPS by a General Practitioner (GP).
- Participants have no history of chronic diseases (cancer, cervical nerve root compression, heart arrhythmias, including hyperthyroid, muscle weakness, seizure, skin infection at the upper back, spinal cord injury, stroke).
- Participants have ability to move the upper limbs.
- Participants reported no use of pacemakers or strong pain relievers, no allergies to metals, gels, or cleaning products, and no pre-existing severe muscle soreness.
You may not qualify if:
- Participants less 18 years old with no myofascial trigger points in the trapezius muscle.
- Participants to have history of chronic diseases (cancer, cervical nerve root compression, heart arrhythmias, including hyperthyroid, muscle weakness, seizure, skin infection at the upper back, spinal cord injury, stroke).
- Participants cannot move the upper limbs.
- Participants reported use of pacemakers or strong pain relievers, and allergies to metals, gels, or cleaning products, and pre-existing severe muscle soreness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Bathlead
- Suranaree University of Technologycollaborator
Study Sites (1)
Department of Electronic and Electrical Engineering
Bath, BA2 7AY, United Kingdom
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
SEEKAOW CHURPROONG, MD.
University of Bath, United Kingdom.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- Treatments were administered in a computer-generated randomised order, concealed from participants.The principal researcher collected all anonymous data for blinded analysis.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 27, 2025
First Posted
January 2, 2026
Study Start
November 25, 2022
Primary Completion
March 28, 2024
Study Completion
September 20, 2025
Last Updated
January 2, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
"Participants' data being shared within the research team", as noted in the consent form. Data will not be shared with other researchers unless they formally join the research team.